Medical Literature Monitoring (MLM-AI)
The first product in development is aimed at Medical Literature Monitoring, which is part of routine pharmacovigilance activities.
MLM-AI empowers medicinal product licence holders, sponsors, patients, healthcare professionals and scientists with accurate information about safety, efficacy and quality of medicinal products.
MLM-AI is a cloud-based SaaS or API tool.
•Automates the detection of adverse events using NLP
•Reduce literature monitoring cost and time
•Produce higher quality results and better insights
Artificial Intelligence Solutions for Pharmacovigilance & Clinical Safety
biologit develops new technology using Artificial Intelligence to tackle the cost and complexity of pharmacovigilance & clinical safety.
Our vision is to help to keep patients safe by simplifying and speeding the detection of adverse events from drug development to post-market.
Would you like to know more about the work we do on Pharmacovigilance & Clinical Safety? Please click below.
Meet The Team
biologit is an ADAPT Centre research team working with Professor Lucy Hederman within Trinity College Dublin, School of Computer Sciences & Statistics. Funded by Enterprise Ireland Commercialisation Fund.
Nicole Baker, PhD
Immunologist and Pharmacovigilance Professional with extensive knowledge in global legislation and guidelines for Medical Affairs, Regulatory Affairs, Pharmacovigilance and Clinical Trials, gained by leading and managing global, multi-disciplinary teams. Overall 20 years’ experience gained within Academia, Pharmaceutical Industry, Regulatory Authority and Clinical Research Organisation.
Bruno Ohana, PhD
Experienced Technologist and Engineering Leader with broad industry experience spanning a career of over 20 years, having performed senior engineering/engineering management roles on large scale Cloud Infrastructure, Fintech, Healthcare and Artificial Intelligence Services.
Senior Pharmacy Technician, with 15 years experience with direct contact with patients and very good understanding of Pharmacovigilance and Drug Safety. Recently retrained in Pharmaceutical Business Operations with emphasis in Pharmaceutical and Medical Devices manufacturing and International Regulatory Affairs.